# Varenicline and Combined NRT for Smoking Cessation

> **NCT02271919** · PHASE4 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 631 (actual)

## Conditions studied

- Cigarette Smoker
- Tobacco Use Disorder

## Interventions

- **DRUG:** Nicotine Lozenge
- **DRUG:** Nicotine Patch
- **OTHER:** Placebo
- **OTHER:** Tobacco Cessation Counseling
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT02271919
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-14
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-04-01
- **Target enrollment:** 631 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271919, "Varenicline and Combined NRT for Smoking Cessation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02271919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*